Normal haemostasis and its regulation.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Blood reviews

• Publication date

  1989-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0268-960X(89)90031-3PMID 2692745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of human recombinant interleukin‐Iα on release of prostacyclin from human endothelial cells

  1989cited by this paper
• Studies of the Factor Xa-Dependent Inhibitor of Factor VIIa/Tissue Factor (Extrinsic Pathway Inhibitor) from Cell Supernates of Cultured Human Umbilical Vein Endothelial Cells

  1989cited by this paper
• Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926.

  1989cited by this paper
• The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

  1988cited by this paper
• Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.

  1988cited by this paper
• Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells.

  1988cited by this paper
• Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.

  1988cited by this paper
• Modulation of Heparin Cofactor II Function by S Protein (Vitronectin) and Formation of a Ternary S Protein-Thrombin-Heparin Cofactor II Complex

  1988cited by this paper
• The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.

  1988cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• A SECOND INHIBITOR OF ACTIVATED PROTEIN C (APC)

  1987cited by this paper
• Novel Functions of the Kininogens

  1987cited by this paper
• INACTIVATION OF FACTOR Va BY PIASMIN

  1987cited by this paper
• Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily.

  1987cited by this paper
• Role of the Contact System in Fibrinolysis

  1987cited by this paper
• Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene.

  1987cited by this paper
• Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.

  1987cited by this paper
• Proteolysis of factor Va by factor Xa and activated protein C.

  1987cited by this paper
• IMMUNOLOGICAL SIMILARITIES BETWEEN PLASMA AND URINARY PROTEIN C INHIBITORS (PCIs) AND URINARY UROKINASE INHIBITOR (UKI)

  1987cited by this paper
• Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.

  1987cited by this paper
• Characterization of the inhibition of tissue factor in serum.

  1987cited by this paper
• ACTIVATION OF HUMAN ENDOTHELIAL TYPE PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) BY NEGATIVELY CHARGED PHOSPHOLIPIDS

  1987cited by this paper
• Binding of plasminogen to cultured human endothelial cells.

  1986cited by this paper
• Specificity of the Thrombin-Induced Release of Tissue Plasminogen Activator from Cultured Human Endothelial Cells

  1986cited by this paper
• Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.

  1986cited by this paper
• Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.

  1986cited by this paper
• Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor Va.

  1986cited by this paper
• VON WILLEBRAND FACTOR, NOW CLONED

  1986cited by this paper
• Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S

  1986cited by this paper
• High molecular weight kininogen is an inhibitor of platelet calpain.

  1986cited by this paper
• Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells

  1986cited by this paper
• S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.

  1986cited by this paper
• Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells.

  1986cited by this paper
• The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin.

  1986cited by this paper
• Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells.

  1986cited by this paper
• Activation of human factor VII in the initiation of tissue factor-dependent coagulation.

  1986cited by this paper
• Isolation of a new specific plasminogen activator in hibitor from pregnancy plasma

  1986cited by this paper
• The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin.

  1985cited by this paper
• Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.

  1985cited by this paper
• Histidine-rich glycoprotein inhibits the antithrombin activity of heparin cofactor II in the presence of heparin or dermatan sulfate.

  1985cited by this paper
• Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions.

  1985cited by this paper
• Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.

  1985cited by this paper
• Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.

  1985cited by this paper
• Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall.

  1985cited by this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cited by this paper
• Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.

  1985cited by this paper
• Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor.

  1985cited by this paper
• Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity.

  1985cited by this paper
• An endothelial cell-dependent pathway of coagulation.

  1985cited by this paper
• Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

  1985cited by this paper
• Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells.

  1985cited by this paper
• Plasminogen activation and regulation of pericellular proteolysis.

  1985cited by this paper
• The regulation of human factor XIIa by plasma proteinase inhibitors.

  1985cited by this paper
• Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation.

  1985cited by this paper
• 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX.

  1985cited by this paper
• The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation.

  1985cited by this paper
• The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X.

  1985cited by this paper
• Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.

  1985cited by this paper
• Endothelial Cells Produce a Lipoxygenase Derived Chemo-Repellent which Influences Platelet/Endothelial Cell Interactions – Effect of Aspirin and Salicylate

  1985cited by this paper
• Characterization of the interaction between factor Xa and bovine aortic endothelial cells.

  1985cited by this paper
• Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels.

  1984cited by this paper
• Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

  1984cited by this paper
• Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V.

  1984cited by this paper
• Synthesis of coagulation factor V by cultured aortic endothelium.

  1984cited by this paper
• Complex formation of platelet thrombospondin with histidine-rich glycoprotein.

  1984cited by this paper
• Isolation and characterization of thrombomodulin from human placenta.

  1984cited by this paper
• Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.

  1984cited by this paper
• Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro.

  1984cited by this paper
• Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator.

  1984cited by this paper
• Inhibition of the thromboplastin response of endothelial cells in vitro.

  1984cited by this paper
• Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.

  1984cited by this paper
• Biosynthesis and metabolism of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid by human umbilical vein endothelial cells.

  1984cited by this paper
• Mechanism of inhibition of activated protein C by protein C inhibitor.

  1984cited by this paper
• Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.

  1984cited by this paper
• Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.

  1984cited by this paper
• Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.

  1984cited by this paper
• Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets

  1984cited by this paper
• Inhibitors of the Fibrinolytic Enzyme System

  1984cited by this paper
• A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen.

  1983cited by this paper
• The factor Xa-catalyzed activation of factor V.

  1983cited by this paper
• Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma.

  1983cited by this paper
• The release of platelet-activating factor from human endothelial cells in culture.

  1983cited by this paper
• Inactivation of kallikrein in human plasma.

  1983cited by this paper
• Human plasma proteinase inhibitors.

  1983cited by this paper
• Sulfated proteoglycans synthesized by vascular endothelial cells in culture.

  1983cited by this paper
• Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma.

  1983cited by this paper
• Activation of heparin cofactor II by dermatan sulfate.

  1983cited by this paper
• Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase.

  1983cited by this paper
• Functional prothrombinase complex assembly on isolated monocytes and lymphocytes.

  1983cited by this paper
• Thrombin activity of fibrin thrombi and soluble plasmic derivatives.

  1983cited by this paper
• Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma.

  1983cited by this paper
• Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition.

  1982cited by this paper
• Effects of tertiary amine local anesthetics on von Willebrand factor-dependent platelet function: alteration of membrane reactivity and degradation of GPIb by a calcium-dependent protease(s).

  1982cited by this paper
• Circular dichroism spectroscopy of heparin-antithrombin interactions.

  1982cited by this paper
• Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.

  1982cited by this paper
• Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.

  1982cited by this paper
• Blood cell membranes and haemostasis.

  1982cited by this paper
• Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.

  1982cited by this paper
• Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.

  1982cited by this paper
• Effect of removing sialic acids from endothelium on the adherence of circulating platelets in arteries in vivo

  1982cited by this paper

• Gastrointestinal endoscopy in cirrhotic patient: Issues on the table

  2021cites this paper
• Association between vitamin K intake and mortality in the Danish Diet, Cancer, and Health cohort

  2021cites this paper
• Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study

  2021cites this paper
• The interaction between the complement system and hemostatic factors.

  2020cites this paper
• Platelet Adhesion on Commercially Pure Titanium Plates in Vitro II. Immunofluorescence Visualization of PDGF-B, TGFβ1, and PPARγ Released from Activated Adherent Platelets

  2019cites this paper
• Advances in Antiplatelet Agents

  2017cites this paper
• Ringhalexin from Hemachatus haemachatus: A novel inhibitor of extrinsic tenase complex

  2016cites this paper
• Characteristics of protrombin pool of patients with ischemic stroke

  2016cites this paper
• Accumulation of CD62P during storage of apheresis platelet concentrates and the role of CD62P in transfusion-related acute lung injury.

  2015cites this paper
• Accumulation of CD 62 P during storage of apheresis platelet concentrates and the role of CD 62 P in transfusion-related acute lung injury

  2015cites this paper
• The portal vein‐variceal anastomosis: an important technique for establishing portal vein inflow

  2014cites this paper
• Blood transfusion during cardiac surgery is associated with inflammation and coagulation in the lung: a case control study

  2011cites this paper
• Transfusion-related acute lung injury in the critically ill: a translational approach

  2010cites this paper
• Primary Fibrinolysis Is Integral in the Pathogenesis of the Acute Coagulopathy of Trauma

  2010cites this paper
• chapter 5 – COAGULOPATHIES AND SICKLE CELL DISEASE

  2010cites this paper
• The divergent clinical presentations of transfusion-related acute lung injury illustrated by two case reports.

  2010cites this paper
• Supernatant of Aged Erythrocytes Causes Lung Inflammation and Coagulopathy in a “Two-Hit” In Vivo Syngeneic Transfusion Model

  2010cites this paper
• Innovative Tests of Plasmatic Hemostasis

  2008cites this paper
• Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives

  2007cites this paper
• Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression.

  2005cites this paper
• Platelets are mitogenic for periosteum‐derived cells

  2003cites this paper
• The future of nutrition and wound healing.

  2001cites this paper
• Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin or 2,2',4,4',5,5'-hexachlorobiphenyl on vitamin K-dependent blood coagulation in male and female WAG/Rij-rats.

  1999cites this paper
• Anti-fibrinolytic therapy in thoracic aortic surgery.

  1999cites this paper
• Time line of wound healing.

  1998cites this paper
• Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways

  1997cites this paper
• Safety and efficacy of aprotinin in profoundly hypothermic circulatory arrest.

  1997cites this paper
• The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit.

  1997cites this paper
• WOUND HEALING IN SEPSIS AND TRAUMA

  1995cites this paper
• Antithrombin III inhibits thrombin-induced proliferation in human arterial smooth muscle cells.

  1994cites this paper
• Tumor necrosis factor-alpha alters the metabolism of endothelial cell proteoglycans.

  1994cites this paper
• Fibrin induction of interleukin-8 expression in corneal endothelial cells in vitro.

  1994cites this paper
• Aprotinin in perspective.

  1993cites this paper
• Postoperative multiple organ dysfunction syndrome associated with gut mucosal hypoperfusion, increased neutrophil degranulation and C1-esterase inhibitor depletion.

  1993cites this paper
• Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.

  1993cites this paper
• Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery

  1993cites this paper
• Endothelial cell dysfunction in HIV infection.

  1992cites this paper
• Vitamin K metabolism and nutriture.

  1992cites this paper
• Thrombotic thrombocytopenic purpura associated with the acquired immune deficiency syndrome.

  1992cites this paper
• Pharmacological modulation of fibrinolysis by antithrombotic and cardiovascular drugs.

  1992cites this paper
• Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production

  1991cites this paper
• Protein S deficiency and HIV infection.

  1991cites this paper
• Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.

  1990cites this paper